Postoperative Cardiac Recovery and Outcomes

Published on 07/02/2015 by admin

Filed under Anesthesiology

Last modified 07/02/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 991 times

Chapter 26 Postoperative Cardiac Recovery and Outcomes

Care of the cardiac surgical patient has become increasingly specialized and patient care has become more complicated. Not only are clinical outcomes important, reflected in mortality and morbidity statistics, but the costs associated with delivering patient care are also playing an increasingly greater role in determining clinical practice.

Cardiac anesthesia itself has fundamentally shifted from a high-dose narcotic technique to a balanced approach using moderate-dose narcotics, shorter-acting muscle relaxants, and volatile anesthetics. This has primarily been driven by a realization that high-dose narcotics delay extubation and recovery after surgery. This new paradigm has also led to renewed interest in perioperative pain management involving multimodal techniques that facilitate rapid tracheal extubation such as regional blocks, intrathecal morphine, and supplementary nonsteroidal anti-inflammatory drugs (NSAIDs). In addition to changes in anesthetic practice, the type of patients presenting for cardiac surgery is changing. Patients are now older and have more associated comorbidities (stroke, myocardial infarction [MI], renal failure). Treatment options for coronary artery disease have expanded, ranging from medical therapy only to percutaneous interventions and surgery. Surgical options, however, have also expanded and include conventional coronary artery bypass grafting (CABG), off-pump coronary artery bypass grafting (OPCAB), minimally direct invasive coronary artery bypass grafting (MIDCAB), and robotically assisted coronary artery bypass grafting (RACAB) techniques. Change has also taken place in the recovery of cardiac patients. Whereas cardiac surgical procedures used to be associated with a high mortality and long intensive care unit (ICU) stays, today’s moderate doses of narcotics allow for rapid ventilator weaning and discharge from the ICU within 24 hours. This has prompted a shift from the classic model of recovering patients in the traditional ICU manner, with weaning protocols and intensive observation, to management more in keeping with the recovery room practice of early extubation and rapid discharge. This, in turn, has shifted the care of cardiac patients to more specialized postcardiac surgical recovery units.

Finally, clinical outcomes have driven change in the management of cardiac patients and are increasingly the focus of research. Intraoperative management now exists within the continuum of preoperative assessment and postoperative care. The outcomes of a patient within the hospital setting are only one small aspect of success. Long-term mortality, morbidity, and quality-of-life indicators are becoming the gold standard in determining benefit or harm interventions.

FAST TRACK CARDIAC SURGERY CARE

Anesthetic Techniques

There have been few trials comparing inhalation agents for fast track cardiac anesthesia (FTCA). Several studies have examined the effectiveness of propofol versus inhalation agents, most demonstrated reductions in myocardial enzyme release (CK-MB, troponin I) and preservation of myocardial function in patients receiving inhalation agents.1 Although this endpoint is a surrogate for myocardial damage and does not show improved outcome per se, CK-MB release after CABG may be associated with poor outcome (Box 26-1).

The choice of muscle relaxant in FTCA is important to reduce the incidence of muscle weakness in the cardiac recovery area (CRA), which may delay tracheal extubation. Randomized trials have compared rocuronium (0.5 to 1 mg/kg) versus pancuronium (0.1 mg/kg) and found significant differences in residual paralysis in the ICU, and statistically significant delays were found in the time to extubation in the pancuronium group.2 None of the trials used reversal agents, so the use of pancuronium appears acceptable as long as neostigmine or edrophonium is administered to patients with residual neuromuscular weakness.

There have been several trials examining the use of different short-acting narcotic agents during FTCA. In these trials, fentanyl, remifentanil, and sufentanil were all found to be efficacious for early tracheal extubation. The anesthetic drugs and their suggested dosages are given in Table 26-1.

Table 26-1 Suggested Dosages for Fast Track Cardiac Anesthesia

Induction
Narcotic

Muscle relaxant

Hypnotic

Maintenance Narcotic

Hypnotic

Transfer to Cardiac Recovery Area Narcotic

Hypnotic

MAC = minimal alveolar concentration.

From Mollhoff T, Herregods L, Moerman A, et al: Comparative efficacy and safety of remifentanil and fentanyl in “fast track” coronary artery bypass graft surgery: A randomized, double-blind study. Br J Anaesth 87: 718, 2001; Engoren M, Luther G, Fenn-Buderer N: A comparison of fentanyl, sufentanil, and remifentanil for fast-track cardiac anesthesia. Anesth Analg 93: 859, 2001; and Cheng DC, Newman MF, Duke P, et al: The efficacy and resource utilization of remifentanil and fentanyl in fast-tract coronary artery bypass graft surgery: A prospective randomized, double-blinded controlled, multi-center trial. Anesth Analg 92:1094, 2001.

Evidence Supporting Fast Track Cardiac Recovery

There are several randomized trials and a meta-analysis of randomized trials that have addressed the question of safety of FTCA.3 None of the trials was able to demonstrate differences in outcomes between the fast track group and the conventional anesthesia group, but meta-analysis of the randomized trials demonstrated a reduction in the duration of intubation by 8 hours (Fig. 26-1) and the ICU length of stay by 5 hours in favor of the fast track group. However, the length of hospital stay was not statistically different.

One concern with FTCA is the potential for an increase in the incidence of adverse events, notably awareness. Awareness in patients undergoing FTCA was systematically investigated and the reported incidence of explicit intraoperative awareness was 0.3%. This is comparable to the reported incidence during conventional cardiac surgery. This suggests that FTCA does not increase the incidence of awareness compared with conventional cardiac surgery.

FTCA appears safe in comparison to conventional high-dose narcotic anesthesia. It reduces the duration of ventilation and ICU length of stay considerably without increasing the incidence of awareness or other adverse events. It also appears effective at reducing costs and resource utilization. As such, it is the standard of care in many cardiac centers. The usual practice at many institutions is to treat all patients as fast track candidates with the goal of allowing early tracheal extubation for every patient. However, if complications occur that would prevent early tracheal extubation, then the management strategy is modified accordingly. It has been demonstrated that the risk factors for delayed tracheal extubation (>10 hours) are increased age, female gender, postoperative use of intra-aortic balloon pump (IABP), inotropes, bleeding, and atrial arrhythmia. The risk factors for prolonged ICU length of stay (>48 hours) are those of delayed tracheal extubation plus preoperative MI and postoperative renal insufficiency. Care should be taken to avoid excess bleeding (antifibrinolytics) and to treat arrhythmias either prophylactically or on occurrence (β-blockers, amiodarone).

Postcardiac Surgical Recovery Models

The failure of many randomized FTCA trials to show reductions in resource utilization likely stems from the traditional ICU models used by these centers during the study period. Even when trials were combined in a meta-analysis, the ICU length of stay was reduced only by 5 hours despite patients being extubated a mean of 8 hours earlier.3 Typically, patients who are extubated within the first 24 hours of ICU admission are transferred to the ward on postoperative day 1 in the morning or early afternoon. This allows the following daytime cardiac cases to have available ICU beds but prevents patient transfers during night-time hours. Two models have been proposed to deal with this issue: the parallel model and the integrated model. In the parallel model, patients are admitted directly to a CRA, where they are monitored with 1:1 nursing care until tracheal extubation. Following this, the level of care is reduced to reflect reduced nursing requirements with ratios of 1:2 or 1:3. Any patients requiring overnight ventilation are transferred to the ICU for continuation of care. The primary drawback with the parallel model is the physical separation of the CRA and ICU, which leads to two separate units and thus does not eliminate the requirement to transfer patients. The integrated model overcomes these limitations because all patients are admitted to the same physical area, but postoperative management such as nursing-to-patient ratio is variable based on patient requirements. Because nursing care accounts for 45% to 50% of ICU costs, reducing the nursing requirements where possible creates the greatest saving. Other cost savings from reductions in arterial blood gases measurement, use of sedative drugs, and ventilator maintenance are small. The goal is a postoperative unit that allows variable levels of monitoring and care based on patient need. Furthermore, FTCA has been demonstrated to be a safe and cost-effective practice that decreases resource utilization after patient discharge from the index hospitalization up to 1-year follow-up.4

INITIAL MANAGEMENT OF FAST TRACK CARDIAC ANESTHESIA PATIENTS: THE FIRST 24 HOURS

On arrival in the CRA, initial management of cardiac patients consists of ensuring an efficient transfer of care from operating room staff to CRA staff while at the same time maintaining stable patient vital signs. The anesthesiologist should relay important clinical parameters to the CRA team. To accomplish this, many centers have devised hand-off sheets to aid in the transfer of care. The patient’s temperature should be recorded, and, if it is low, active rewarming measures should be initiated with the goal of rewarming the patient to 36.5°C. Shivering may be treated with low intravenous doses of meperidine (12.5 to 25 mg). Hyperthermia, however, is common within the first 24 hours after cardiac surgery and may be associated with an increase in neurocognitive dysfunction, possibly as a result of hyperthermia exacerbating cardiopulmonary bypass (CPB)−induced neurologic injury (Box 26-2).

Ventilation Management: Admission to Tracheal Extubation

Ventilatory requirements should be managed with the goal of early tracheal extubation (Table 26-2). Arterial blood gas samples are initially drawn within 30 minutes after admission and then repeated as necessary. Patients should be awake and cooperative, hemodynamically stable, and have no active bleeding with coagulopathy. Respiratory strength should be assessed by hand grip or head lift to ensure complete reversal of neuromuscular blockade. The patient’s temperature should be above 36°C, preferably normothermic. When these conditions are met and arterial blood gas results are within the normal range, tracheal extubation may take place. Blood for arterial blood gas analysis should be drawn about 30 minutes after tracheal extubation to ensure adequate ventilation with maintenance of PaO2 and PaCO2. Inability to extubate patients as a result of respiratory failure, hemodynamic instability, or large amounts of mediastinal drainage will necessitate more complex weaning strategies. Some patients may arrive after extubation in the operating room. Careful attention should be paid to these patients. The patient’s respiratory rate should be monitored every 5 minutes during the first several hours. A blood sample should be drawn on admission and 30 minutes later to ensure the patient is not retaining carbon dioxide. If the patient’s respirations become compromised, ventilatory support should be provided. Simple measures such as reminders to breathe may be effective in the narcotized/anesthetized patient. Low intravenous doses of naloxone (0.04 mg) may also be beneficial. Trials of continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP) may provide enough support to allow adequate ventilation. Reintubation should be avoided because it may delay recovery; however, it may become necessary if the just-mentioned measures fail, resulting in hypoxemia, hypercarbia, and a declining level of consciousness.

Table 26-2 Ventilation Management Goals during the Initial Trial of Weaning from Extubation

Maintain arterial blood gases

Buy Membership for Anesthesiology Category to continue reading. Learn more here